Table 1 Characteristics at baseline for patients with impaired renal function receiving renal biopsy or not
Characteristics | Group | P-value | ||
|---|---|---|---|---|
Total (n = 300) | Renal biopsy (n = 150) | Non-Renal biopsy (n = 150) | ||
Age (years) | 53.0(40.3, 62.0) | 52.5(38.0, 60.0) | 55.0(42.0, 64.0) | 0.090 |
Male, n (%) | 184 (61.3%) | 89(59.3%) | 95 (63.3%) | 0.477 |
Preoperative medical condition, n (%) | ||||
Diabetes mellitus | 50(16.7%) | 21(14.0%) | 29(19.3%) | 0.215 |
Hypertension | 182(60.7%) | 88 (58.7%) | 94(62.7%) | 0.478 |
Follow-up time (months) | 37.6(21.9, 51.8) | 41.1(12.78, 54.48) | 36.2(24.3, 50.7) | 0.951 |
Serum creatinine (umol/L) | 120.0(103.9, 147.0) | 124.2(104.0, 160.1) | 116.0(103.4, 142.1) | 0.102 |
Haemoglobin (g/L) | 132.2 ± 20.4 | 129.8 ± 15.6 | 134.7 ± 24.2 | 0.098 |
Serum albumin (g/L) | 41.0(38.5,43.7) | 40.1(38.5, 42.8) | 42.4(37.8, 44.7) | 0.100 |
24 h UPE (g/d) | 0.94(0.30, 1.99) | 1.04(0.36, 2.09) | 0.59(0.17, 1.87) | 0.083 |
Hematuria | 0.105 | |||
No | 158 | 72 | 86 | |
Yes | 142 | 78 | 64 | |
eGFR (ml/min/1.73m2)※ | 53.8 ± 15.9 | 52.2 ± 14.4 | 55.3 ± 17.1 | 0.100 |